Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.80
+1.40 (8.54%)
May 30, 2025, 4:08 PM HKT

HKG:2315 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
403.85417.66626.62466.45750.04
Short-Term Investments
7.257.899.15106.98207.37
Trading Asset Securities
-8.498.2--
Cash & Short-Term Investments
411.1434.04643.97573.42957.41
Cash Growth
-5.29%-32.60%12.30%-40.11%-
Accounts Receivable
229.61142.38107.68103.0967.23
Other Receivables
11.046.044.1714.9614.7
Receivables
240.65148.43111.85118.0581.93
Inventory
5.399.923.7321.6510.21
Other Current Assets
159.41130.69139.74161.1198.08
Total Current Assets
816.54723.05919.3874.241,148
Property, Plant & Equipment
1,3491,4511,5991,3911,136
Long-Term Investments
222.61241.24250.819.6910.09
Other Intangible Assets
20.6728.1330.656.062.43
Long-Term Deferred Tax Assets
0.96----
Other Long-Term Assets
5.066.16-21.8630.77
Total Assets
2,4152,4492,8002,3032,327
Accounts Payable
115.48175.23146.19102.4487.6
Accrued Expenses
30.1827.8951.6253.6627.41
Current Portion of Long-Term Debt
208.14176.84126.67--
Current Portion of Leases
17.8626.3644.9426.914.11
Current Income Taxes Payable
12.814.514.25.021.42
Current Unearned Revenue
102.1969.2256.3861.5847.51
Other Current Liabilities
48.2697.56176.06196.96150.42
Total Current Liabilities
534.91577.62606.05446.56328.47
Long-Term Debt
193.84173.9152.17--
Long-Term Leases
150.45167.01191.5162.966.81
Long-Term Unearned Revenue
84.987.0789.9392.890.12
Long-Term Deferred Tax Liabilities
-1.9---
Other Long-Term Liabilities
612.62651.48709.36448.55382.88
Total Liabilities
1,5771,6591,6491,051868.28
Common Stock
399.4399.4399.4374.93360
Additional Paid-In Capital
1,9921,9921,9921,5161,219
Retained Earnings
-1,754-1,787-1,404-802.32-256.75
Treasury Stock
-32.77-27.18-18.99--
Comprehensive Income & Other
229.3209.09178.32159.03130.69
Total Common Equity
834.06785.891,1461,2471,453
Minority Interest
4.554.554.554.764.83
Shareholders' Equity
838.6790.441,1511,2521,458
Total Liabilities & Equity
2,4152,4492,8002,3032,327
Total Debt
570.28544.11415.2889.880.92
Net Cash (Debt)
-159.18-110.07228.69483.62876.5
Net Cash Growth
---52.71%-44.82%-
Net Cash Per Share
-0.40-0.280.601.336.79
Filing Date Shares Outstanding
399.4399.4399.4396.69129.06
Total Common Shares Outstanding
399.4399.4399.4374.93129.06
Working Capital
281.62145.43313.25427.68819.17
Book Value Per Share
2.091.972.873.3311.26
Tangible Book Value
813.39757.761,1161,2411,451
Tangible Book Value Per Share
2.041.902.793.3111.24
Machinery
1,5021,4371,2081,107849.69
Construction In Progress
1.95.19268.29181.96210.83
Leasehold Improvements
232.8240.53161.75166.4344.07
Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.